Screener
Bicara Therapeutics BCAX Q2 2026 earnings
Reported August 11, 2026 · Before market open
EPS-$0.82In line
EPS estimate-$0.82
Next report
Nov 9, 2026 (in a month)EPS estimate-$0.84
Versus estimates
FAQ
- When did Bicara Therapeutics report Q2 2026 earnings?
- Bicara Therapeutics (BCAX) reported Q2 2026 earnings on August 11, 2026 before market open.
- What were Bicara Therapeutics's Q2 2026 revenue and EPS?
- Bicara Therapeutics reported eps of $-0.82 for Q2 2026.
- Did Bicara Therapeutics beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.82 by $0.00.
- How did Bicara Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 64.0% from $-0.50.
- Where can I find Bicara Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-055500) and the 10-Q periodic report (0001628280-26-055765) directly on SEC EDGAR. The filing index links above go to sec.gov.
